Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial.

Palmu AA, Toropainen M, Kaijalainen T, Siira L, Lahdenkari M, Nieminen H, Syrjänen RK, Kilpi TM, Jokinen J.

Pediatr Infect Dis J. 2017 Dec;36(12):1193-1200. doi: 10.1097/INF.0000000000001705.

PMID:
28737627
2.

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.

Vesikari T, Forsten A, Seppä I, Kaijalainen T, Puumalainen T, Soininen A, Traskine M, Lommel P, Schoonbroodt S, Hezareh M, Moreira M, Borys D, Schuerman L.

J Pediatric Infect Dis Soc. 2016 Sep;5(3):237-248. doi: 10.1093/jpids/piw010. Epub 2016 Apr 28.

3.

Long-term survival of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis as isolates and in nasopharyngeal specimens in frozen STGG storage medium.

Kaijalainen T, Palmu A.

J Microbiol Methods. 2015 Jul;114:38-9. doi: 10.1016/j.mimet.2015.04.012. Epub 2015 Apr 30.

PMID:
25937246
4.

Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus.

Palmu AA, Kaijalainen T, Jokinen J, Kilpi TM.

Pediatr Infect Dis J. 2015 Jul;34(7):796-7. doi: 10.1097/INF.0000000000000728.

PMID:
25886787
5.

Diet as a risk factor for pneumococcal carriage and otitis media: a cross-sectional study among children in day care centers.

Tapiainen T, Paalanne N, Arkkola T, Renko M, Pokka T, Kaijalainen T, Uhari M.

PLoS One. 2014 Mar 5;9(3):e90585. doi: 10.1371/journal.pone.0090585. eCollection 2014.

6.

Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study.

Palmu AA, Saukkoriipi A, Snellman M, Jokinen J, Torkko P, Ziegler T, Kaijalainen T, Hausdorff WP, Verlant V, Kilpi TM.

Scand J Infect Dis. 2014 Apr;46(4):250-9. doi: 10.3109/00365548.2013.876509. Epub 2014 Jan 29.

PMID:
24475952
7.

Antimicrobial resistance in relation to sero- and genotypes among invasive Streptococcus pneumoniae in Finland, 2007-2011.

Siira L, Jalava J, Kaijalainen T, Ollgren J, Lyytikäinen O, Virolainen A.

Microb Drug Resist. 2014 Apr;20(2):124-30. doi: 10.1089/mdr.2013.0156. Epub 2013 Nov 22.

PMID:
24266666
8.

Comparative analysis of Streptococcus pneumoniae transmission in Portuguese and Finnish day-care centres.

Pessoa D, Hoti F, Syrjänen R, Sá-Leão R, Kaijalainen T, Gomes MG, Auranen K.

BMC Infect Dis. 2013 Apr 18;13:180. doi: 10.1186/1471-2334-13-180.

9.

Pneumococcemia in children--a retrospective study before universal pneumococcal vaccinations.

Karppa H, Vuento R, Toropainen M, Kaijalainen T, Siira L, Korppi M.

Acta Paediatr. 2013 May;102(5):514-9. doi: 10.1111/apa.12194. Epub 2013 Feb 28.

PMID:
23398588
10.

Adenoidectomy in young children and serum IgG antibodies to pneumococcal surface protein A and choline binding protein A.

Mattila PS, Hammarén-Malmi S, Saxen H, Kaijalainen T, Käyhty H, Tarkkanen J.

Int J Pediatr Otorhinolaryngol. 2012 Nov;76(11):1569-74. doi: 10.1016/j.ijporl.2012.07.013. Epub 2012 Jul 24.

PMID:
22835927
11.

From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping.

Siira L, Kaijalainen T, Lambertsen L, Nahm MH, Toropainen M, Virolainen A.

J Clin Microbiol. 2012 Aug;50(8):2727-31. doi: 10.1128/JCM.00689-12. Epub 2012 Jun 12.

12.

Comparison of the severity and outcome of invasive pneumococcal infections in children and adults.

Renko M, Kukkola HL, Kauma H, Tapiainen T, Kaijalainen T, Uhari M.

Pediatr Infect Dis J. 2012 Jul;31(7):785-8. doi: 10.1097/INF.0b013e318259cab7.

PMID:
22544053
13.

Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects.

Palmu AA, Kaijalainen T, Saukkoriipi A, Leinonen M, Kilpi TM.

Scand J Infect Dis. 2012 Jun;44(6):433-8. doi: 10.3109/00365548.2011.652162. Epub 2012 Jan 21.

PMID:
22263905
14.

Clonality behind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland.

Siira L, Jalava J, Tissari P, Vaara M, Kaijalainen T, Virolainen A.

Eur J Clin Microbiol Infect Dis. 2012 May;31(5):867-71. doi: 10.1007/s10096-011-1386-8. Epub 2011 Aug 26.

PMID:
21870053
15.

Prevalence of pilus-encoding islets and clonality of pneumococcal isolates from children with acute otitis media.

Vainio A, Kaijalainen T, Hakanen AJ, Virolainen A.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):515-9. doi: 10.1007/s10096-010-1112-y. Epub 2011 Feb 10.

PMID:
21308386
16.

Effect of xylitol and other carbon sources on Streptococcus pneumoniae biofilm formation and gene expression in vitro.

Kurola P, Tapiainen T, Sevander J, Kaijalainen T, Leinonen M, Uhari M, Saukkoriipi A.

APMIS. 2011 Feb;119(2):135-42. doi: 10.1111/j.1600-0463.2010.02703.x. Epub 2010 Dec 1.

PMID:
21208281
17.

Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men.

Jounio U, Juvonen R, Bloigu A, Silvennoinen-Kassinen S, Kaijalainen T, Kauma H, Peitso A, Saukkoriipi A, Vainio O, Harju T, Leinonen M.

Clin Respir J. 2010 Oct;4(4):222-9. doi: 10.1111/j.1752-699X.2009.00179.x.

PMID:
20887345
18.

Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae.

Melin M, Trzciński K, Antonio M, Meri S, Adegbola R, Kaijalainen T, Käyhty H, Väkeväinen M.

Infect Immun. 2010 Dec;78(12):5252-61. doi: 10.1128/IAI.00739-10. Epub 2010 Sep 20.

19.

A report of Streptococcus pneumoniae serotype 6D in Europe.

Nahm MH, Oliver MB, Siira L, Kaijalainen T, Lambertsen LM, Virolainen A.

J Med Microbiol. 2011 Jan;60(Pt 1):46-8. doi: 10.1099/jmm.0.023853-0. Epub 2010 Sep 9.

20.

Risk of invasive pneumococcal infections among working age adults with asthma.

Klemets P, Lyytikäinen O, Ruutu P, Ollgren J, Kaijalainen T, Leinonen M, Nuorti JP.

Thorax. 2010 Aug;65(8):698-702. doi: 10.1136/thx.2009.132670.

PMID:
20685743
21.

Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infection.

Kurola P, Erkkilä L, Kaijalainen T, Palmu AA, Hausdorff WP, Poolman J, Jokinen J, Kilpi TM, Leinonen M, Saukkoriipi A.

J Med Microbiol. 2010 Oct;59(Pt 10):1140-5. doi: 10.1099/jmm.0.016956-0. Epub 2010 Jul 8.

PMID:
20616188
22.

Adenoidectomy and nasopharyngeal carriage of Streptococcus pneumoniae in young children.

Mattila PS, Hammarén-Malmi S, Saxen H, Kaijalainen T, Käyhty H, Tarkkanen J.

Arch Dis Child. 2010 Sep;95(9):696-702. doi: 10.1136/adc.2009.165654. Epub 2010 May 26.

PMID:
20504840
23.

The development of a 16S rRNA gene based PCR for the identification of Streptococcus pneumoniae and comparison with four other species specific PCR assays.

El Aila NA, Emler S, Kaijalainen T, De Baere T, Saerens B, Alkan E, Deschaght P, Verhelst R, Vaneechoutte M.

BMC Infect Dis. 2010 Apr 29;10:104. doi: 10.1186/1471-2334-10-104.

24.

Biofilm formation by Streptococcus pneumoniae isolates from paediatric patients.

Tapiainen T, Kujala T, Kaijalainen T, Ikäheimo I, Saukkoriipi A, Renko M, Salo J, Leinonen M, Uhari M.

APMIS. 2010 Apr;118(4):255-60. doi: 10.1111/j.1600-0463.2010.02587.x.

PMID:
20402670
25.

An outbreak of pneumonia associated with S. pneumoniae at a military training facility in Finland in 2006.

Vainio A, Lyytikäinen O, Sihvonen R, Kaijalainen T, Teirilä L, Rantala M, Lehtinen P, Ruuska P, Virolainen A.

APMIS. 2009 Jul;117(7):488-91. doi: 10.1111/j.1600-0463.2009.02463.x.

PMID:
19594488
26.

Xylitol and capsular gene expression in Streptococcus pneumoniae.

Kurola P, Tapiainen T, Kaijalainen T, Uhari M, Saukkoriipi A.

J Med Microbiol. 2009 Nov;58(Pt 11):1470-3. doi: 10.1099/jmm.0.011700-0. Epub 2009 Jul 9.

PMID:
19589898
27.

Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006.

Siira L, Rantala M, Jalava J, Hakanen AJ, Huovinen P, Kaijalainen T, Lyytikäinen O, Virolainen A.

Antimicrob Agents Chemother. 2009 May;53(5):2066-73. doi: 10.1128/AAC.01464-08. Epub 2009 Mar 9.

28.

Trends and geographical variation in invasive pneumococcal infections in Finland.

Klemets P, Lyytikäinen O, Ruutu P, Kaijalainen T, Leinonen M, Ollgren J, Nuorti JP.

Scand J Infect Dis. 2008;40(8):621-8. doi: 10.1080/00365540801938931. Erratum in: Scand J Infect Dis. 2009;41(6-7):544.

PMID:
18979600
29.

Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, Kaijalainen T, Kilpi TM, Käyhty HM.

Clin Vaccine Immunol. 2008 Oct;15(10):1555-63. doi: 10.1128/CVI.00177-08. Epub 2008 Aug 27.

30.

Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae among children in St Petersburg, Russia.

Kaijalainen T, Kharit SM, Kvetnaya AS, Sirkiä K, Herva E, Parkov OV, Nohynek H.

Clin Microbiol Infect. 2008 May;14(5):507-10. doi: 10.1111/j.1469-0691.2008.01967.x. Epub 2008 Mar 1.

31.

Defining the population-based burden of nosocomial pneumococcal bacteremia.

Lyytikäinen O, Klemets P, Ruutu P, Kaijalainen T, Rantala M, Ollgren J, Nuorti JP.

Arch Intern Med. 2007 Aug 13-27;167(15):1635-40.

PMID:
17698686
32.

Treatment of acute otitis media with probiotics in otitis-prone children-a double-blind, placebo-controlled randomised study.

Hatakka K, Blomgren K, Pohjavuori S, Kaijalainen T, Poussa T, Leinonen M, Korpela R, Pitkäranta A.

Clin Nutr. 2007 Jun;26(3):314-21. Epub 2007 Mar 13.

PMID:
17353072
33.

Molecular epidemiology of telithromycin-resistant pneumococci in Finland.

Rantala M, Nyberg S, Lindgren M, Huovinen P, Jalava J, Skyttä R, Teirilä L, Vainio A, Virolainen-Julkunen A, Kaijalainen T.

Antimicrob Agents Chemother. 2007 May;51(5):1885-7. Epub 2007 Feb 26. No abstract available.

34.

A successful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus.

Hanage WP, Kaijalainen T, Saukkoriipi A, Rickcord JL, Spratt BG.

J Clin Microbiol. 2006 Mar;44(3):743-9.

35.

Nasal middle meatal specimen bacteriology as a predictor of the course of acute respiratory infection in children.

Kristo A, Uhari M, Kontiokari T, Glumoff V, Kaijalainen T, Leinonen M, Luotonen J, Koivunen P, Kujala T, Pokka T, Alho OP.

Pediatr Infect Dis J. 2006 Feb;25(2):108-12.

PMID:
16462285
36.

Real-time pneumolysin polymerase chain reaction with melting curve analysis differentiates pneumococcus from other alpha-hemolytic streptococci.

Kaijalainen T, Saukkoriipi A, Bloigu A, Herva E, Leinonen M.

Diagn Microbiol Infect Dis. 2005 Dec;53(4):293-9.

PMID:
16360553
37.

Presence of viral and bacterial pathogens in the nasopharynx of otitis-prone children. A prospective study.

Pitkäranta A, Roivainen M, Blomgren K, Peltola J, Kaijalainen T, Räty R, Ziegler T, Rönkkö E, Hatakka K, Korpela R, Poussa T, Leinonen M, Hovi T.

Int J Pediatr Otorhinolaryngol. 2006 Apr;70(4):647-54. Epub 2005 Sep 27.

PMID:
16198005
38.

Using multilocus sequence data to define the pneumococcus.

Hanage WP, Kaijalainen T, Herva E, Saukkoriipi A, Syrjänen R, Spratt BG.

J Bacteriol. 2005 Sep;187(17):6223-30.

39.

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, Malley R.

PLoS Med. 2005 Jan;2(1):e15. Epub 2005 Jan 25.

40.

[Lack of spleen or spleen malfunction--serious risk factor for sepsis].

Kanerva M, Varpula T, Carlson P, Kaijalainen T, Nurkka A, Käyhty H, Seppänen M.

Duodecim. 2004;120(20):2459-62. Finnish. No abstract available.

PMID:
15641515
41.

Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland.

Hanage WP, Kaijalainen TH, Syrjänen RK, Auranen K, Leinonen M, Mäkelä PH, Spratt BG.

Infect Immun. 2005 Jan;73(1):431-5.

42.

Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.

Palmu AA, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM.

Clin Infect Dis. 2005 Jan 1;40(1):52-7. Epub 2004 Dec 6.

PMID:
15614692
43.

Ultrastructure of Streptococcus pneumoniae after exposure to xylitol.

Tapiainen T, Sormunen R, Kaijalainen T, Kontiokari T, Ikäheimo I, Uhari M.

J Antimicrob Chemother. 2004 Jul;54(1):225-8. Epub 2004 Jun 9.

PMID:
15190027
44.
45.

Isolation of pneumococcal DNA from nasopharyngeal samples for real-time, quantitative PCR: comparison of three methods.

Saukkoriipi A, Kaijalainen T, Kuisma L, Ojala A, Leinonen M.

Mol Diagn. 2003;7(1):9-15.

PMID:
14529315
46.

Comparison of five genotypic techniques for identification of optochin-resistant pneumococcus-like isolates.

Verhelst R, Kaijalainen T, De Baere T, Verschraegen G, Claeys G, Van Simaey L, De Ganck C, Vaneechoutte M.

J Clin Microbiol. 2003 Aug;41(8):3521-5.

47.

Evaluation of gene-technological and conventional methods in the identification of Streptococcus pneumoniae.

Kaijalainen T, Rintamäki S, Herva E, Leinonen M.

J Microbiol Methods. 2002 Sep;51(1):111-8.

PMID:
12069896
48.

Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000.

Pihlajamäki M, Kaijalainen T, Huovinen P, Jalava J; Finnish Study Group for Antimicrobial Resistance.

J Antimicrob Chemother. 2002 May;49(5):785-92.

PMID:
12003972
49.

Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old.

Syrjänen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK.

J Infect Dis. 2001 Aug 15;184(4):451-9. Epub 2001 Jul 6.

PMID:
11471103
50.

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

Kilpi T, Herva E, Kaijalainen T, Syrjänen R, Takala AK.

Pediatr Infect Dis J. 2001 Jul;20(7):654-62.

PMID:
11465836

Supplemental Content

Loading ...
Support Center